BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/8/2025 4:16:08 AM | Browse: 7 | Download: 0
Publication Name World Journal of Methodology
Manuscript ID 114604
Country United States
Category Health Policy & Services
Manuscript Type Opinion Review
Article Title Why does hepatitis B remain underprioritized? A view through lived experience
Manuscript Source Invited Manuscript
All Author List Yasmin Ibrahim, Anousha Qureshi, Michaela Jackson, Beatrice Zovich, Catherine Freeland, Monue Flomo, Kenson Alik, Ravshan Yakubov, Li Hui Chen, Philip Yehoah and Chari Cohen
Funding Agency and Grant Number
Corresponding Author Yasmin Ibrahim, Associate Professor, Director, MD, Principal Investigator, Senior Researcher, Patient Engagement Program, Hepatitia B Foundation, Yasmin Ibrahim, Hepatitis B Foundation, 3805 Old Easton Road, Doylestown, Pennsylvania, United States, 18902-8400. Email: <email>yasmin.ibrahim@hepb.org</email>, Doylestown, Pennsylvania, 18902, United States. yasmin.ibrahim@hepb.org
Key Words Hepatitis B; Elimination; Under-prioritization; Health equity; Global; Hepatitis B virus; Chronic hepatitis B; People living with hepatitis B virus
Core Tip The article explores why chronic hepatitis B (CHB) infection, despite affecting 260 million people globally, remains underprioritized. Only 3% of those infected receive treatment, and stigma, discrimination, and systemic neglect persist. Through lived experiences of people with hepatitis B worldwide, this article explores barriers to progress-such as marginalization of impacted population and inequitable funding among others, and draws lessons from human immunodeficiency virus, coronavirus disease 2019, and Ebola, where advocacy, political will, and investment drove change. It calls for stronger collaboration, greater investment in care and prevention, integration of disease programs, and inclusion of patient-reported outcomes to accelerate elimination and improve the lives of people living with hepatitis B.
Citation Ibrahim Y, Qureshi A, Jackson M, Zovich B, Freeland C, Flomo M, Alik K, Yakubov R, Chen LH, Yeboah PK, Cohen C. Why does hepatitis B remain underprioritized? A view through lived experience. World J Methodol 2025; In press
Received
2025-09-24 02:04
Peer-Review Started
2025-09-24 02:04
First Decision by Editorial Office Director
2025-10-10 09:11
Return for Revision
2025-10-10 09:11
Revised
2025-10-30 19:59
Publication Fee Transferred
Second Decision by Editor
2025-12-08 02:38
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2025-12-08 04:16
Articles in Press
2025-12-08 04:16
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2222-0682 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com